Consolidated Balance Sheets - USD ($)	Dec. 31, 2019	Dec. 31, 2018
CURRENT ASSETS
Cash	$ 6,995,525	$ 186,204
Research and development tax credit receivable	568,139	592,215
Other tax receivable	77,225	37,382
Joint development cost receivable		17,989
Prepaid expenses	97,623	15,552
Prepaid expenses - related party	26,266
TOTAL CURRENT ASSETS	7,764,778	849,342
Operating lease - right of use asset - related party	191,543
Acquired in-process research and development intangible assets	16,514,000	16,514,000
TOTAL ASSETS	24,470,321	17,363,342
CURRENT LIABILITIES
Accounts payable and accrued liabilities	401,989	553,221
Accounts payable and accrued liabilities - related parties	290,102	270,545
Operating lease, current liability - related party	8,288
TOTAL CURRENT LIABILITIES	700,379	823,766
Long-term operating lease liability - related party	160,164
TOTAL LIABILITIES	860,543	823,766
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY
Preferred stock, $0.001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding
Common stock, $0.001 par value, 200,000,000 shares authorized, 10,770,948 and 8,719,441 shares issued and outstanding, respectively	10,771	8,719
Additional paid-in capital	44,833,703	25,446,196
Common stock issuable	50,000	4,676,000
Accumulated other comprehensive income (loss)	(8,515)	6,529
Accumulated deficit	(21,276,181)	(13,597,868)
TOTAL STOCKHOLDERS' EQUITY	23,609,778	16,539,576
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 24,470,321	$ 17,363,342